Latest Headlines

  1. Clinical Leader Forum Names Boston and Philadelphia As 2018 Locations

    Philadelphia Agenda Announcement and Advisory Board Introduction

    November 20, 2017, Erie, PA: Life Science Leader and are excited to announce that Clinical Leader Forum will take place in Boston and Philadelphia in 2018. The Boston event is scheduled for October 3 – 4, 2018 at the State Room Boston. The Philadelphia event is scheduled for May 9-10, 2018 at the Hilton Philadelphia City Avenue.

  2. Universal Pipette Filter Plugs

    iNLABTEC AG has introduced Universal Pipette Filter Plugs designed to provide a final barrier to protect the internal components of your pipettes from contamination due to accidental splashes during pipetting, foaming samples or aerosolized vapours. 

  3. Roche Launches DISCOVERY Teal HRP Chromogen Detection Kit To Advance Tissue-Based Cancer Research

    Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the DISCOVERY Teal HRP kit, the newest addition to the comprehensive collection of modular-based detection kits to identify and profile biomarkers and cell populations in tissue-based research

  4. CIRCULOGENE Introduces Single-Tube, Blood-Based Microsatellite Instability (MSI) Biomarker Testing For Multiple Cancers

    CIRCULOGENE, a leading liquid biopsy company advancing precision medicine through personalized molecular genetics testing, has announced the availability of microsatellite instability (MSI) biomarker testing for multiple cancer types

  5. Aquila Diagnostic Systems Inc. Releases Independent Trial Results For Its AccutasVET Tapeworm Fecal Test

    Aquila Diagnostic Systems Inc. (“Aquila”) is pleased to announce results of an independent laboratory trial for its point-of-care AccutasVET DNA Tapeworm fecal test based on Aquila’s patented molecular diagnostics hydrogel technology

  6. Illumina Grows Clinical IVD Portfolio With Introduction Of NextSeq 550Dx System And Expanded Use Of MiSeqDx System

    Illumina, Inc. announced recently the introduction of its NextSeq 550Dx instrument, the company’s second FDA-regulated and CE-IVD marked next-generation sequencing (NGS) system

  7. Macrogen Corp.'s Clinical NGS Laboratory Receives CAP Accreditation

    Macrogen Corp. ( announces that its Clinical Lab that provides clinical NGS services has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs

  8. LabCorp Announces New Expanded Use For PD-L1 Test With Bristol-Myers Squibb’s OPDIVO

    LabCorp a leading global life sciences company, recently announced the U.S. availability of the PD-L1 IHC 28-8 pharmDx assay as a complementary diagnostic for two newly approved indications in connection with the use of Bristol-Myers Squibb’s OPDIVO (nivolumab) to treat patients with metastatic urothelial carcinoma, also referred to as bladder cancer, and squamous cell carcinoma of the head and neck

  9. Inozyme Pharma Raises $49M In A Series A Financing To Develop Therapies For Rare Diseases Affecting Soft Tissues And Bone

    Inozyme Pharma, Inc., a biotechnology company developing novel medicines to treat rare diseases of calcification, affecting soft tissues and bone, recently announced it has raised a $49M Series A financing

  10. Versatile Evaporator Available In Different Optimised Configurations

    The compact benchtop EZ-2 Series evaporator from Genevac has been designed to meet or exceed the solvent removal needs of most laboratory scientists